Losartan failed to reduce lung injury or improve clinical outcomes in patients hospitalized with COVID-19, researchers reported in JAMA Network Open.
“Even though this particular drug was not effective for the treatment of COVID-19, repurposing inexpensive and relatively safe medications remains an important approach to contain health care costs,” Michael A. Puskarich, MD, MS, associate professor in emergency medicine at University of Minnesota Medical School and emergency physician at Hennepin Healthcare, Minneapolis, said in a related press release. “Finding effective